Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_assertion type Assertion NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_head.
- NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_assertion description "[Our findings warrant a further pre-clinical evaluation of an experimental anti-glioma therapy with TRAIL and Troglitazone, potentially in conjunction with a MAP kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_provenance.
- NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_assertion evidence source_evidence_literature NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_provenance.
- NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_assertion SIO_000772 19158480 NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_provenance.
- NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_assertion wasDerivedFrom befree-2016 NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_provenance.
- NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_assertion wasGeneratedBy ECO_0000203 NP715787.RAVVOzuDDCq82affDA1o0mBUIWlTMx0uLfSHLWd6E-ewg130_provenance.